Drug innovation is getting more valuable. We can't afford to undermine it. By Tomas J. Philipson Lawmakers in both parties are increasingly embracing the idea of price controls on medicines -- and in doing so, they're making a losing bet. Price controls involve a fundamental tradeoff: lower prices t...
